• 23. Dezember 2024

ISA Pharmaceuticals announces start of first Phase I/II clinical trial of its SLP®-AMPLIVANT® conjugates

ByISA Pharmaceuticals

Feb 26, 2015
#8722 Leiden University Medical Center to study novel immunotherapeutic in HPV-positive head neck cancer patients
Teile den Beitrag mit Freunden

Kommentar verfassen